Neogen Corporation Class Action Lawsuit Information for Investors

Neogen Corporation Class Action Lawsuit Overview
Levi & Korsinsky, LLP is reaching out to investors in Neogen Corporation regarding a class action securities lawsuit. This lawsuit is focused on allegations of securities fraud that may have impacted investors.
Understanding the Class Definition
The class action aims to recover losses for those who were affected by the alleged securities violations from January 5, 2023, to June 3, 2025. It is essential for affected investors to stay informed about their potential claims and options for recovery.
Case Details
The lawsuit claims that Neogen Corporation and certain executives made materially false and misleading statements. These statements suggested that the integration with the Food Safety Division of a significant company was progressing positively, which was not the case. When inefficiencies in the integration surfaced, the defendants allegedly downplayed them, assuring investors that these issues would be swiftly addressed.
Next Steps for Investors
If you suffered financial losses as a result of investments in Neogen Corporation during the outlined period, it is crucial to act quickly. Interested parties have until September 16, 2025, to request to be appointed as lead plaintiff. However, it is important to note that participation in any recovery does not require a lead plaintiff status.
Frequently Asked Questions
What is the lawsuit about?
The lawsuit claims that Neogen Corporation misled investors about the integration with the Food Safety Division of a major company, resulting in financial losses.
Who is eligible to participate in the class action?
Investors who experienced losses in Neogen Corporation from January 5, 2023, to June 3, 2025, may be eligible to participate.
How can investors get more information?
Investors can reach out to Levi & Korsinsky or visit their website for more details regarding the lawsuit and their rights.
What happens if I don't sign up as a lead plaintiff?
You can still qualify for any potential recovery even if you do not take on the role of lead plaintiff.
Are there costs involved in participating?
There are no upfront costs for class members to participate in this lawsuit.
Conclusion
The team at Levi & Korsinsky has extensive experience in securities litigation, having achieved substantial settlements for investors over the past two decades. This firm’s history reflects its commitment to helping shareholders navigate complex legal scenarios. Interested investors, especially those affiliated with Neogen Corporation (NASDAQ: NEOG), should stay updated and consider their options regarding this class action lawsuit.
For additional inquiries, investors can contact Joseph E. Levi, Esq. at the dedicated email or phone number provided by Levi & Korsinsky.
If you are a class member interested in joining this class action lawsuit against Neogen Corporation, reach out to Levi & Korsinsky, LLP.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.